Tag: nabriva therapeutics

September 6, 2019

Nabriva Therapeutics Receives $5M Payment Under License Agreement with Sinovant Sciences

Nabriva Therapeutics (NASDAQ:NBRV) has announced that it has received a US$5 million payment under its license agreement with Sinovant Sciences...
August 19, 2019

Nabriva Notches First FDA Nod for Pneumonia Treatment

The FDA's approval of Xenleta is the first of its kind in almost two decades and will treat community-acquired bacterial...
May 12, 2019

5 Top Weekly NASDAQ Biotech Stocks: Evofem Climbs 71 Percent

Last week's other top NASDAQ biotech stocks were OptimizeRx, Dyadic International, Mersana Therapeutics and Nabriva Therapeutics.
January 4, 2019

Nabriva Therapeutics Announces Acceptance of the New Drug Application for Intravenous CONTEPO

Nabriva Therapeutics (NASDAQ:NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of innovative anti-infective agents to treat serious infections,...